The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome

Objective Innate and adaptive immunity may contribute to gland dysfunction in patients with primary Sjögren's syndrome (pSS). The P2X7 receptor (P2X7R)–NLRP3 inflammasome complex modulates the release of the inflammatory cytokines IL‐1β and IL‐18. The presence of P2X7R in salivary glands sugges...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of internal medicine 2013-11, Vol.274 (5), p.480-489
Hauptverfasser: Baldini, C., Rossi, C., Ferro, F., Santini, E., Seccia, V., Donati, V., Solini, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 489
container_issue 5
container_start_page 480
container_title Journal of internal medicine
container_volume 274
creator Baldini, C.
Rossi, C.
Ferro, F.
Santini, E.
Seccia, V.
Donati, V.
Solini, A.
description Objective Innate and adaptive immunity may contribute to gland dysfunction in patients with primary Sjögren's syndrome (pSS). The P2X7 receptor (P2X7R)–NLRP3 inflammasome complex modulates the release of the inflammatory cytokines IL‐1β and IL‐18. The presence of P2X7R in salivary glands suggests an interesting scenario for the initiation and amplification of the innate immune response in pSS. Therefore, the aim of this study was to assess the role of the P2X7R–NLRP3 inflammasome in pSS. Subjects and Methods Twenty‐one consecutive patients with pSS according to the American–European Consensus Group criteria and 15 patients with sicca syndrome (i.e. without Sjögren's syndrome, non‐SS) were enrolled in this study, together with six control (CTL) subjects. Expression of the P2X7R‐NLRP3 platform and IL‐18 was determined by real‐time PCR and western blotting in gland specimens and peripheral lymphomonocytes; data were related to patients\x92 clinical, serological and histopathological characteristics. The presence of IL‐18 was determined in gland and saliva samples. Results P2X7R expression was significantly higher in salivary glands from individuals with pSS than in those from non‐SS and CTL subjects. Accordingly, the gene expression levels of the inflammasome components NLRP3, ASC and caspase‐1 were significantly higher in pSS gland specimens, and this was paralleled by an increased expression of mature IL‐18 in pSS saliva samples. The expression of both the P2X7R and the inflammasome components was a marker of disease‐related glandular involvement, being increased in patients with anti‐Ro/SSA positivity and correlated with focus score. Conclusion The results of this study suggest an involvement of the P2X7R–inflammasome–caspase‐1–IL‐18 axis in the development of pSS exocrinopathy. This finding provides the basis for studying the complex mechanisms underlying pSS, as well as for developing novel potential therapeutic strategies.
doi_str_mv 10.1111/joim.12115
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1443413146</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1443413146</sourcerecordid><originalsourceid>FETCH-LOGICAL-j2705-5dbdccd2831b08c77a1921614fc12870c1ffac1b4a6b23aee7d2e895ec0c3c03</originalsourceid><addsrcrecordid>eNo9kUtOw0AMhkcIREthwwHQ7GCTMp7Jc4kqHkVFRaILdtFk4rSJMpmQaQRlxR24CxfgJpyE9AHe2LI__7L8E3IKbAhdXBYm10PgAN4e6YPwPYcHkb9P-izyXMcPOeuRI2sLxkAwnx2SHhdRVwi_T95nC6SP_DmgDSqsl6b5-fjMq6yUWktrNFJldF3iG11ISyVtTIk0r6g2aVvKZV7N6XKx7mw3uv1Vp2RrU9kNVze5ll3vqfj-mjdYnVtqV1XadMrH5CCTpcWTXR6Q2c31bHTnTKa349HVxCl4wDzHS5NUqZSHAhIWqiCQEHHwwc0U8DBgCrJMKkhc6SdcSMQg5RhGHiqmhGJiQC62snVjXlq0y1jnVmFZygpNa2NwXeGCANfv0LMd2iYa03h3fPz3rg6ALfCal7j6nwOL10bEayPijRHx_XT8sKnELzOIfxo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1443413146</pqid></control><display><type>article</type><title>The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome</title><source>Wiley Free Content</source><source>MEDLINE</source><source>IngentaConnect Free/Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Baldini, C. ; Rossi, C. ; Ferro, F. ; Santini, E. ; Seccia, V. ; Donati, V. ; Solini, A.</creator><creatorcontrib>Baldini, C. ; Rossi, C. ; Ferro, F. ; Santini, E. ; Seccia, V. ; Donati, V. ; Solini, A.</creatorcontrib><description>Objective Innate and adaptive immunity may contribute to gland dysfunction in patients with primary Sjögren's syndrome (pSS). The P2X7 receptor (P2X7R)–NLRP3 inflammasome complex modulates the release of the inflammatory cytokines IL‐1β and IL‐18. The presence of P2X7R in salivary glands suggests an interesting scenario for the initiation and amplification of the innate immune response in pSS. Therefore, the aim of this study was to assess the role of the P2X7R–NLRP3 inflammasome in pSS. Subjects and Methods Twenty‐one consecutive patients with pSS according to the American–European Consensus Group criteria and 15 patients with sicca syndrome (i.e. without Sjögren's syndrome, non‐SS) were enrolled in this study, together with six control (CTL) subjects. Expression of the P2X7R‐NLRP3 platform and IL‐18 was determined by real‐time PCR and western blotting in gland specimens and peripheral lymphomonocytes; data were related to patients\x92 clinical, serological and histopathological characteristics. The presence of IL‐18 was determined in gland and saliva samples. Results P2X7R expression was significantly higher in salivary glands from individuals with pSS than in those from non‐SS and CTL subjects. Accordingly, the gene expression levels of the inflammasome components NLRP3, ASC and caspase‐1 were significantly higher in pSS gland specimens, and this was paralleled by an increased expression of mature IL‐18 in pSS saliva samples. The expression of both the P2X7R and the inflammasome components was a marker of disease‐related glandular involvement, being increased in patients with anti‐Ro/SSA positivity and correlated with focus score. Conclusion The results of this study suggest an involvement of the P2X7R–inflammasome–caspase‐1–IL‐18 axis in the development of pSS exocrinopathy. This finding provides the basis for studying the complex mechanisms underlying pSS, as well as for developing novel potential therapeutic strategies.</description><identifier>ISSN: 0954-6820</identifier><identifier>EISSN: 1365-2796</identifier><identifier>DOI: 10.1111/joim.12115</identifier><identifier>PMID: 23906036</identifier><language>eng</language><publisher>England</publisher><subject>Blotting, Western ; Carrier Proteins - analysis ; Carrier Proteins - physiology ; Case-Control Studies ; Female ; Humans ; inflammasome ; Inflammasomes - physiology ; Inflammation - physiopathology ; Interleukin-18 - analysis ; Interleukin-18 - physiology ; Interleukin-1beta - analysis ; Interleukin-1beta - physiology ; interleukin‐18 ; Middle Aged ; Monocytes - chemistry ; Monocytes - physiology ; NLR Family, Pyrin Domain-Containing 3 Protein ; P2X7 receptor ; Real-Time Polymerase Chain Reaction ; Receptors, Purinergic P2X7 - analysis ; Receptors, Purinergic P2X7 - physiology ; Salivary Glands - chemistry ; Salvia - chemistry ; Sjogren's Syndrome - immunology ; Sjogren's Syndrome - physiopathology ; Sjögren's syndrome</subject><ispartof>Journal of internal medicine, 2013-11, Vol.274 (5), p.480-489</ispartof><rights>2013 The Association for the Publication of the Journal of Internal Medicine</rights><rights>2013 The Association for the Publication of the Journal of Internal Medicine.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjoim.12115$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjoim.12115$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23906036$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baldini, C.</creatorcontrib><creatorcontrib>Rossi, C.</creatorcontrib><creatorcontrib>Ferro, F.</creatorcontrib><creatorcontrib>Santini, E.</creatorcontrib><creatorcontrib>Seccia, V.</creatorcontrib><creatorcontrib>Donati, V.</creatorcontrib><creatorcontrib>Solini, A.</creatorcontrib><title>The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome</title><title>Journal of internal medicine</title><addtitle>J Intern Med</addtitle><description>Objective Innate and adaptive immunity may contribute to gland dysfunction in patients with primary Sjögren's syndrome (pSS). The P2X7 receptor (P2X7R)–NLRP3 inflammasome complex modulates the release of the inflammatory cytokines IL‐1β and IL‐18. The presence of P2X7R in salivary glands suggests an interesting scenario for the initiation and amplification of the innate immune response in pSS. Therefore, the aim of this study was to assess the role of the P2X7R–NLRP3 inflammasome in pSS. Subjects and Methods Twenty‐one consecutive patients with pSS according to the American–European Consensus Group criteria and 15 patients with sicca syndrome (i.e. without Sjögren's syndrome, non‐SS) were enrolled in this study, together with six control (CTL) subjects. Expression of the P2X7R‐NLRP3 platform and IL‐18 was determined by real‐time PCR and western blotting in gland specimens and peripheral lymphomonocytes; data were related to patients\x92 clinical, serological and histopathological characteristics. The presence of IL‐18 was determined in gland and saliva samples. Results P2X7R expression was significantly higher in salivary glands from individuals with pSS than in those from non‐SS and CTL subjects. Accordingly, the gene expression levels of the inflammasome components NLRP3, ASC and caspase‐1 were significantly higher in pSS gland specimens, and this was paralleled by an increased expression of mature IL‐18 in pSS saliva samples. The expression of both the P2X7R and the inflammasome components was a marker of disease‐related glandular involvement, being increased in patients with anti‐Ro/SSA positivity and correlated with focus score. Conclusion The results of this study suggest an involvement of the P2X7R–inflammasome–caspase‐1–IL‐18 axis in the development of pSS exocrinopathy. This finding provides the basis for studying the complex mechanisms underlying pSS, as well as for developing novel potential therapeutic strategies.</description><subject>Blotting, Western</subject><subject>Carrier Proteins - analysis</subject><subject>Carrier Proteins - physiology</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Humans</subject><subject>inflammasome</subject><subject>Inflammasomes - physiology</subject><subject>Inflammation - physiopathology</subject><subject>Interleukin-18 - analysis</subject><subject>Interleukin-18 - physiology</subject><subject>Interleukin-1beta - analysis</subject><subject>Interleukin-1beta - physiology</subject><subject>interleukin‐18</subject><subject>Middle Aged</subject><subject>Monocytes - chemistry</subject><subject>Monocytes - physiology</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein</subject><subject>P2X7 receptor</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Receptors, Purinergic P2X7 - analysis</subject><subject>Receptors, Purinergic P2X7 - physiology</subject><subject>Salivary Glands - chemistry</subject><subject>Salvia - chemistry</subject><subject>Sjogren's Syndrome - immunology</subject><subject>Sjogren's Syndrome - physiopathology</subject><subject>Sjögren's syndrome</subject><issn>0954-6820</issn><issn>1365-2796</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kUtOw0AMhkcIREthwwHQ7GCTMp7Jc4kqHkVFRaILdtFk4rSJMpmQaQRlxR24CxfgJpyE9AHe2LI__7L8E3IKbAhdXBYm10PgAN4e6YPwPYcHkb9P-izyXMcPOeuRI2sLxkAwnx2SHhdRVwi_T95nC6SP_DmgDSqsl6b5-fjMq6yUWktrNFJldF3iG11ISyVtTIk0r6g2aVvKZV7N6XKx7mw3uv1Vp2RrU9kNVze5ll3vqfj-mjdYnVtqV1XadMrH5CCTpcWTXR6Q2c31bHTnTKa349HVxCl4wDzHS5NUqZSHAhIWqiCQEHHwwc0U8DBgCrJMKkhc6SdcSMQg5RhGHiqmhGJiQC62snVjXlq0y1jnVmFZygpNa2NwXeGCANfv0LMd2iYa03h3fPz3rg6ALfCal7j6nwOL10bEayPijRHx_XT8sKnELzOIfxo</recordid><startdate>201311</startdate><enddate>201311</enddate><creator>Baldini, C.</creator><creator>Rossi, C.</creator><creator>Ferro, F.</creator><creator>Santini, E.</creator><creator>Seccia, V.</creator><creator>Donati, V.</creator><creator>Solini, A.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201311</creationdate><title>The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome</title><author>Baldini, C. ; Rossi, C. ; Ferro, F. ; Santini, E. ; Seccia, V. ; Donati, V. ; Solini, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j2705-5dbdccd2831b08c77a1921614fc12870c1ffac1b4a6b23aee7d2e895ec0c3c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Blotting, Western</topic><topic>Carrier Proteins - analysis</topic><topic>Carrier Proteins - physiology</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Humans</topic><topic>inflammasome</topic><topic>Inflammasomes - physiology</topic><topic>Inflammation - physiopathology</topic><topic>Interleukin-18 - analysis</topic><topic>Interleukin-18 - physiology</topic><topic>Interleukin-1beta - analysis</topic><topic>Interleukin-1beta - physiology</topic><topic>interleukin‐18</topic><topic>Middle Aged</topic><topic>Monocytes - chemistry</topic><topic>Monocytes - physiology</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein</topic><topic>P2X7 receptor</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Receptors, Purinergic P2X7 - analysis</topic><topic>Receptors, Purinergic P2X7 - physiology</topic><topic>Salivary Glands - chemistry</topic><topic>Salvia - chemistry</topic><topic>Sjogren's Syndrome - immunology</topic><topic>Sjogren's Syndrome - physiopathology</topic><topic>Sjögren's syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baldini, C.</creatorcontrib><creatorcontrib>Rossi, C.</creatorcontrib><creatorcontrib>Ferro, F.</creatorcontrib><creatorcontrib>Santini, E.</creatorcontrib><creatorcontrib>Seccia, V.</creatorcontrib><creatorcontrib>Donati, V.</creatorcontrib><creatorcontrib>Solini, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baldini, C.</au><au>Rossi, C.</au><au>Ferro, F.</au><au>Santini, E.</au><au>Seccia, V.</au><au>Donati, V.</au><au>Solini, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome</atitle><jtitle>Journal of internal medicine</jtitle><addtitle>J Intern Med</addtitle><date>2013-11</date><risdate>2013</risdate><volume>274</volume><issue>5</issue><spage>480</spage><epage>489</epage><pages>480-489</pages><issn>0954-6820</issn><eissn>1365-2796</eissn><abstract>Objective Innate and adaptive immunity may contribute to gland dysfunction in patients with primary Sjögren's syndrome (pSS). The P2X7 receptor (P2X7R)–NLRP3 inflammasome complex modulates the release of the inflammatory cytokines IL‐1β and IL‐18. The presence of P2X7R in salivary glands suggests an interesting scenario for the initiation and amplification of the innate immune response in pSS. Therefore, the aim of this study was to assess the role of the P2X7R–NLRP3 inflammasome in pSS. Subjects and Methods Twenty‐one consecutive patients with pSS according to the American–European Consensus Group criteria and 15 patients with sicca syndrome (i.e. without Sjögren's syndrome, non‐SS) were enrolled in this study, together with six control (CTL) subjects. Expression of the P2X7R‐NLRP3 platform and IL‐18 was determined by real‐time PCR and western blotting in gland specimens and peripheral lymphomonocytes; data were related to patients\x92 clinical, serological and histopathological characteristics. The presence of IL‐18 was determined in gland and saliva samples. Results P2X7R expression was significantly higher in salivary glands from individuals with pSS than in those from non‐SS and CTL subjects. Accordingly, the gene expression levels of the inflammasome components NLRP3, ASC and caspase‐1 were significantly higher in pSS gland specimens, and this was paralleled by an increased expression of mature IL‐18 in pSS saliva samples. The expression of both the P2X7R and the inflammasome components was a marker of disease‐related glandular involvement, being increased in patients with anti‐Ro/SSA positivity and correlated with focus score. Conclusion The results of this study suggest an involvement of the P2X7R–inflammasome–caspase‐1–IL‐18 axis in the development of pSS exocrinopathy. This finding provides the basis for studying the complex mechanisms underlying pSS, as well as for developing novel potential therapeutic strategies.</abstract><cop>England</cop><pmid>23906036</pmid><doi>10.1111/joim.12115</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6820
ispartof Journal of internal medicine, 2013-11, Vol.274 (5), p.480-489
issn 0954-6820
1365-2796
language eng
recordid cdi_proquest_miscellaneous_1443413146
source Wiley Free Content; MEDLINE; IngentaConnect Free/Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Blotting, Western
Carrier Proteins - analysis
Carrier Proteins - physiology
Case-Control Studies
Female
Humans
inflammasome
Inflammasomes - physiology
Inflammation - physiopathology
Interleukin-18 - analysis
Interleukin-18 - physiology
Interleukin-1beta - analysis
Interleukin-1beta - physiology
interleukin‐18
Middle Aged
Monocytes - chemistry
Monocytes - physiology
NLR Family, Pyrin Domain-Containing 3 Protein
P2X7 receptor
Real-Time Polymerase Chain Reaction
Receptors, Purinergic P2X7 - analysis
Receptors, Purinergic P2X7 - physiology
Salivary Glands - chemistry
Salvia - chemistry
Sjogren's Syndrome - immunology
Sjogren's Syndrome - physiopathology
Sjögren's syndrome
title The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T21%3A24%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20P2X7%20receptor%E2%80%93inflammasome%20complex%20has%20a%20role%20in%20modulating%20the%20inflammatory%20response%20in%20primary%20Sj%C3%B6gren's%20syndrome&rft.jtitle=Journal%20of%20internal%20medicine&rft.au=Baldini,%20C.&rft.date=2013-11&rft.volume=274&rft.issue=5&rft.spage=480&rft.epage=489&rft.pages=480-489&rft.issn=0954-6820&rft.eissn=1365-2796&rft_id=info:doi/10.1111/joim.12115&rft_dat=%3Cproquest_pubme%3E1443413146%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1443413146&rft_id=info:pmid/23906036&rfr_iscdi=true